Construction of an Atopic Symptom Questionnaire and Evaluation of Peri-menstrual Atopy in Women of Reproductive Age

Tara Raouf Salih; Darya Saeed Abdulateef

doi:10.54133/ajms.v9i1.2286

Authors

Tara Raouf Salih Department of Basic Medical Sciences, College of Medicine, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq https://orcid.org/0009-0004-9731-6956
Darya Saeed Abdulateef Department of Medical Education, College of Medicine, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq https://orcid.org/0000-0001-6516-8611

DOI:

https://doi.org/10.54133/ajms.v9i1.2286

Keywords:

Atopic Symptoms, Menstrual phases, Perimenstrual atopy, Reproductive-age female

Abstract

Background: Atopic disorders, such as asthma, atopic dermatitis (AD), and allergic rhinitis (AR), are rising globally. In reproductive-age women, hormonal fluctuations during the menstrual cycle can trigger or worsen symptoms, a condition termed perimenstrual atopy (PMA). Despite its prevalence, PMA remains under-recognized, especially in healthy females, and no standardized tool exists for its comprehensive assessment. Objective: To determine PMA occurrence in females with and without diagnosed atopy and to develop and validate the Atopic Symptom Score Questionnaire (ASQ) for PMA evaluation. Methods: This observational study included 145 reproductive-age females (54 atopic, 91 non-atopic) with regular menstrual cycles. The ASQ was constructed by integrating validated tools for asthma, AD, and AR. Content validity was confirmed by experts, and internal reliability was strong. After pilot testing, the finalized ASQ was administered via face-to-face interviews. Participants rated symptom severity and indicated the timing of symptom onset in relation to menstrual phases. Mean ASQ scores and the frequency of PMA were analyzed, and the comparison between atopic and non-atopic groups was conducted. Results: PMA was reported in 29.9% of participants, more often in atopic (40.7%) than non-atopic females (23.3%). The most common symptoms were breathlessness, throat discomfort, and nasal congestion. ASQ scores were significantly higher in atopic individuals (11.5 vs. 2.41, p<0.001), with most exacerbations during menstrual and premenstrual phases. Conclusions: The ASQ is a valid tool for assessing PMA. PMA is common and underdiagnosed, even among non-atopic females, highlighting the need for greater clinical awareness and standardized evaluation.

Downloads

Download data is not yet available.

References

Thomsen SF. Epidemiology and natural history of atopic diseases. Eur Clin Respir J. 2015;2(1):24642. doi: 10.3402/ecrj.v2.24642. DOI: https://doi.org/10.3402/ecrj.v2.24642

Golden DBK, Wang J, Waserman S, Akin C, Campbell RA, Ellis AK, et al. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asma Immunol. 2024;132(2):124-176. doi: 10.10/j.anal.2023.09.015. DOI: https://doi.org/10.1016/j.anai.2023.09.015

Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832-836. doi: 10.1016/j.jaci.2003.12.591. DOI: https://doi.org/10.1016/j.jaci.2003.12.591

Ring J. Terminology of allergic phenomena. Chem Immunol Allergy. 2014;69(1):46–52. doi:10.1159/000358500. DOI: https://doi.org/10.1159/000358500

Ring J, Przybilla B, Ruzicka T, editors, Handbook of Atopic Eczema. Berlin, Heidelberg: Springer Berlin Heidelberg; 2006. doi: 10.1007/3-540-29856-8. DOI: https://doi.org/10.1007/3-540-29856-8

Engler-Chiurazzi EB, Chastain WH, Citron KK, Lambert LE, Kikkeri DN, Shrestha SS. Estrogen, the peripheral immune system and major depression – a reproductive lifespan perspective. Front Behav Neurosci. 2022;16. doi: 10.3389/fnbeh.2022.850623. DOI: https://doi.org/10.3389/fnbeh.2022.850623

Kirmaz C, Yuksel H, Mete N, Bayrak P, Baytur YB. Is the menstrual cycle affecting the skin prick test reactivity? Asian Pac J Allergy Immunol. 2004;22(4):197–203. PMID: 15783132.

Murakami K, Sawada A, Mori T, Sakuyama S, Tokudome Y. Effect of estrogen/progesterone ratio on the differentiation and the barrier function of epidermal keratinocyte and three-dimensional cultured human epidermis. Life Sci. 2022;293:120356. doi: 10.1016/j.lfs.2022.120356. DOI: https://doi.org/10.1016/j.lfs.2022.120356

Graziottin A, Serafini A. Perimenstrual asthma: from pathophysiology to treatment strategies. Multidiscip Respir Med. 2016;11(1):30. doi: 10.1186/s40248-016-0065-0. DOI: https://doi.org/10.1186/s40248-016-0065-0

Weare-Regales N, Chiarella SE, Cardet JC, Prakash YS, Lockey RF. Hormonal effects on asthma, rhinitis, and eczema. J Allergy Clin Immunol Pract. 2022;10(8):2066–2073. doi: 10.1016/j.jaip.2022.04.002. DOI: https://doi.org/10.1016/j.jaip.2022.04.002

Haeggström A, Östberg B, Stjerna P, Graf P, Hallén H. Nasal mucosal swelling and reactivity during a menstrual cycle. ORL. 2000;62(1):39–42. doi: 10.1159/000027713. DOI: https://doi.org/10.1159/000027713

Vrieze A, Postma DS, Kerstjens HAM. Perimenstrual asthma: a syndrome without known cause or cure. J Allergy Clin Immunol. 2003;112(2):271–282. doi: 10.1067/mai.2003.1676. DOI: https://doi.org/10.1067/mai.2003.1676

Farha S, Asosingh K, Laskowski D, Hammel J, Dweik RA, Wiedemann HP, et al. Effects of the menstrual cycle on lung function variables in women with asthma. Am J Respir Crit Care Med. 2009;180(4):304–310. doi: 10.1164/rccm.200904-0497OC. DOI: https://doi.org/10.1164/rccm.200904-0497OC

Chhabra SK, Chhabra P. Gender differences in perception of dyspnea, assessment of control, and quality of life in asthma. J Asthma, 2011;48(6):609–615. doi: 10.3109/02770903.2011.587577. DOI: https://doi.org/10.3109/02770903.2011.587577

Frank RT. The hormonal causes of premenstrual tension. Arch Neurol Psychiatry. 1931;26(5):1053. doi: 10.1001/archneurpsyc.1931.02230110151009. DOI: https://doi.org/10.1001/archneurpsyc.1931.02230110151009

Aissani S, Ararem I, Haouichat H, Haffaf M, Zitouni A. Clinical and spirometric characteristics of premenstrual asthma. Int J of Allergy Medications. 2019;5(1). doi: 10.23937/2572-3308.1510041. DOI: https://doi.org/10.23937/2572-3308.1510041

Murphy VE, Gibson PG. Premenstrual asthma: prevalence, cycle-to-cycle variability and relationship to oral contraceptive use and menstrual symptoms. J ORLAsthma. 2008;45(8):696–704. doi: 10.1080/02770900802207279. DOI: https://doi.org/10.1080/02770900802207279

Wood PR, Smith B, O'Donnell L, Forkner E, Lara M, Peters JI. Quantifying asthma symptoms in adults: the Lara asthma symptom scale. J Allergy Clin Immunol. 2007;120(6):1368–1372. doi: 10.1016/j.jaci.2007.09.025. DOI: https://doi.org/10.1016/j.jaci.2007.09.025

American Thoracic Society. Asthma Control Questionnaire (ACQ). [Internet]. American Thoracic Society; [cited 2025 Jul 12]. Available from: https://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/acq.php

DermNet New Zealand. EASI score. [Internet]. DermNet New Zealand; [cited 2025 Jul 12]. Available from: https://dermnetnz.org/topics/easi-score

Oakley A. SCORAD index. [Internet]. Hamilton, New Zealand: DermNet New Zealand; 2009 [cited 2025 Jul 12]. Available from: https://dermnetnz.org/topics/scorad

Charman CR, Venn AJ, Ravenscroft JC, Williams HC. Translating patient‐oriented eczema measure scores into clinical practice by suggesting severity strata derived using anchor‐based methods. Br J Dermatol. 2013;169(6):1326–1332. doi: 10.1111/bjd.12590. DOI: https://doi.org/10.1111/bjd.12590

Ontosight AI. Total nasal symptom score (TNSS). [Internet]. Ontosight AI; [cited 2025 Jul 12]. Available from: https://ontosight.ai/glossary/term/Total-Nasal-Symptom-Score---TNSS

Ellis AK, Soliman M, Steacy L, Boulay MÈ, Boulet LP, Keith PK, et al. The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. J Allergy Clin Immunol. 2015;135(4):888–894. doi: 10.1186/s13223-015-0082-0. DOI: https://doi.org/10.1016/j.jaci.2014.12.1121

Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med. 1996;156(16):1837–1840. PMID: 8790078. DOI: https://doi.org/10.1001/archinte.1996.00440150091010

Brenner BE, Holmes TM, Mazal B, Camargo CA Jr. Relation between phase of the menstrual cycle and asthma presentations in the emergency department. Thorax. 2005;60(10):806–809. doi: 10.1136/thx.2004.033928. DOI: https://doi.org/10.1136/thx.2004.033928

Eliasson O, Scherzer HH, DeGraff AC. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol. 1986;77(1 Pt 1):87–94. doi: 10.1016/0091-6749(86)90328-3. DOI: https://doi.org/10.1016/0091-6749(86)90328-3

Suzuki K, Hasegawa T, Sakagami T, Koya T, Toyabe S, Akazawa K, et al. Analysis of perimenstrual asthma based on questionnaire surveys in Japan. Allergol Int. 2007;56(3):249–255. doi: 10.2332/allergolint.O-06-475. DOI: https://doi.org/10.2332/allergolint.O-06-475

Mosbeh A, Abdelrahman RM. The impact of pregnancy and phases of the menstrual cycle on atopic dermatitis. Austin J Dermatol. 2017;4(3):1081.

Cho S, Kim HJ, Oh SH, Park CO, Jung JY, Lee KH. The influence of pregnancy and menstruation on the deterioration of atopic dermatitis symptoms. Ann Dermatol. 2010;22(2):180. doi: 10.5021/ad.2010.22.2.180. DOI: https://doi.org/10.5021/ad.2010.22.2.180

Grajczyk A, Sobczyk K, Dżaman K. Nasal and Eustachian tube function during menstrual cycle. Otolaryngol Pol. 2025;79(3):1–8. doi: 10.5604/01.3001.0055.0197. DOI: https://doi.org/10.5604/01.3001.0055.0197

Stübner UP, Gruber D, Berger UE, Toth J, Marks B, Huber J, et al. The influence of female sex hormones on nasal reactivity in seasonal allergic rhinitis. Allergy. 1999;54(8):865–871. doi: 10.1034/j.1398-9995.1999.00961.x. DOI: https://doi.org/10.1034/j.1398-9995.1999.00961.x